XNK Therapeutics one of three winners of Business Sweden's Catalyst program 2023 (Información remitida por la empresa firmante) HUDDINGE, Sweden, July 12, 2023 /PRNewswire/ -- XNK Therapeutics AB today announced that it has been selected as one of three winners of Business Sweden's Catalyst program 2023.
Informe de sustentabilidad 2022 de Atlas Corp.:Los valores ESG integrados impulsan la toma de decisiones
Latest data on lecanemab to be presented at Alzheimer's Association International Conference (AAIC) 2023
Sungrow sigue siendo el número 1 en la entrega de inversores solares fotovoltaicos a nivel mundial en 2022
